Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Food and Drug Administration

Editorial: Easier access to abortion pills is pushing anti-choice activists toward more extreme ideas

The war over abortion rights has moved from the sidewalks in front of medical clinics to pharmacies and mailboxes. The Food and Drug Administration’s loosening of restrictions on abortion pills has provided some degree of protection to women in the post-Roe v. Wade world. But it also has nudged some…

St. Louis Post-Dispatch

Matthew Yglesias: Trump isn’t touting his biggest success

One sunny spring morning in May 2020, President Donald Trump stood in the White House Rose Garden and announced what would turn out to be his administration’s most striking success: Operation Warp Speed, which combined an influx of money with some trimming of bureaucracy to generate safe and effective vaccines…

Tribune News Service

FDA defends vaccine shelf-life extensions

The Food and Drug Administration has said it was following the latest approved safety information when it extended the shelf life of some batches of Pfizer Covid-19 vaccine to 15 months from nine.

Bangkok Post

From analysis to the latest developments in health,
read the most diverse news in one place.

Hundreds of ready-to-eat foods are recalled over possible listeria contamination

The foods are sold under dozens of different brand names, but all recalled products say Fresh Creative Cuisine on the bottom of the label. The recall affects items sold in nine East Coast states.

WEKU

FDA revamping foods program to move past ‘constant turmoil’

The head of the Food and Drug Administration has announced an overhaul of the agency's food safety and nutrition division

The Independent UK

Since when is any amount of lead allowed in baby food?

PHILADELPHIA -- The Food and Drug Administration urged food manufacturers last week to significantly reduce the amount of lead in processed baby food.

The Philadelphia Inquirer

Moderna Scores A Win In RSV — But Its Shares Don't Reflect That

The Food and Drug Administration granted Moderna's experimental RSV vaccine an expedited review, but Moderna stock dipped Monday.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Commentary: We shouldn’t get caught up in the hype over new Alzheimer’s drug

This month, the Food and Drug Administration approved a new drug, lecanemab, for the treatment of Alzheimer’s disease. The drug, sold under the brand name Leqembi, was developed by Japanese pharmaceutical company Eisai and will be marketed commercially in partnership with American pharmaceutical company Biogen. Biogen, notably, is the maker…

Chicago Tribune

FDA revokes authorization for key anti-COVID-19 drug, a blow for vulnerable Americans

The Food and Drug Administration has withdrawn its provisional support for the use of Evusheld, a medication that was once a valuable tool for preventing patients with weakened immune systems from becoming severely ill with COVID-19.

Los Angeles Times

Chicago blood banks look to build trust, end shortages under proposed new donation rules

The FDA announced a draft of new guidelines Friday that would end mandatory three-month abstinence periods for men who have sex with men. For Illinois hospitals and blood banks, the change is long overdue.

Chicago Sun-Times

FDA moves to ease limits on gay, bisexual men donating blood

The Food and Drug Administration announced Friday a proposal to ease restrictions on blood donation by gay and bisexual men. The move was celebrated by LGBTQ rights advocates as “a tremendous leap forward toward elevating science over stigma.”

Tribune News Service

FDA finally clears the way for gay and bisexual men to donate blood

The FDA is expected to hold a public comment period prior to enacting the new policy later this year

The Independent UK

FDA seeks end of regulatory wild west for CBD products

The Food and Drug Administration on Thursday announced that CBD products, increasingly popular but largely unregulated, will soon join the ranks of other more mainstream, regulated products.

Tribune News Service

An FDA committee votes to roll out a new COVID vaccination strategy

Advisers to the U.S. Food and Drug Administration today endorsed a proposal to make big changes in the nation's approach to vaccinating people against COVID-19.

WEKU

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

FDA declines to regulate CBD; calls on Congress for fix

The Food and Drug Administration says there are too many unknowns about CBD products to regulate them as foods or supplements

The Independent UK

FDA food safety official resigns, cites structural issues

The Food and Drug Administration's top food safety official has resigned

Tribune News Service

FDA suit accuses Florida company of making and selling ‘adulterated’ drugs

The Food and Drug Administration has filed a lawsuit accusing a Boca Raton pharmaceutical manufacturer of selling “adulterated” drugs and failure to correct violations cited by the FDA in 2018.

Tribune News Service

FDA decision could increase access to abortion pills across Alaska

A new federal rule change could make it easier for Alaskans to access medical abortions, especially in rural communities.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

How Novo Nordisk Just Expanded Its Diabetes Lead Over Pfizer, Eli Lilly

The Food and Drug Administration expanded the label for Novo Nordisk's oral diabetes medicine, leading NVO stock to jump Friday.

The Conversation

What the FDA's accelerated approval of a new Alzheimer's drug could mean for those with the disease – 5 questions answered about lecanemab

The U.S. Food and Drug Administration approved the medication lecanemab, sold under the brand name Leqembi, on Jan. 6, 2023, through an “accelerated approval pathway” that fast-tracks promising clinical treatments for diseases in which there are no other currently effective options.

Tribune News Service

A new Alzheimer’s drug has been approved. What to know about lecanemab

A new drug that appears to slow early Alzheimer’s disease is coming to the market.

Tribune News Service

Mayo Clinic expert provides perspective on FDA approval of another experimental Alzheimer's drug

The Food and Drug Administration granted accelerated approval of a disease-modifying treatment that could potentially give some patients with Alzheimer's disease something they haven't had before: a medication that may slow the decline of memory and thinking.

Tribune News Service

Editorial: The FDA is right to allow pharmacies to distribute abortion medication

Precisely when human life begins is above our pay grade, but at a time when states are radically restricting women’s right to seek reproductive health care — and forcing rape and incest victims, among others, to give birth — policymakers in Washington ought to be wisely using the levers of…

Asharq Al-Awsat

US Approves New Drug to Treat Alzheimer's Disease

The US Food and Drug Administration on Friday approved a highly anticipated new drug designed to slow cognitive decline in patients in mild and early stages of Alzheimer's disease. The FDA approval of the drug, Leqembi, also known as lecanemab, comes just days after the regulatory agency was harshly criticized…

AFP

US approves new drug to treat Alzheimer's disease

Washington (AFP) - The US Food and Drug Administration on Friday approved a highly anticipated new drug designed to slow cognitive decline in patients in mild and early stages of Alzheimer's disease.

1 … 3 4 5 6

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

National Institutes of Health

62 stories

New England Journal of Medicine

30 stories

Leqembi

24 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.